Lung Cancer Considered

• Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate

  Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate by IASLC

  --------  

  25:28
• The Benefits of Patient Advocacy Groups

  In this episode of Lung Cancer Considered, host Dr. Narjust Florez engages in a discussion with patient advocate Summer Farmen. Listen to the episode to learn about Summer’s journey through diagnosis and treatment, and the importance of patient advocate groups. • Summer Farmen ALKtALK Program Coordinator Board Member, ALK Positive, Inc.

  --------  

  30:07
• Live from TTLC25: Targeted Therapy in SCLC

  In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion on how small cell lung cancer continues to evolve with new treatment options and recent FDA approval. Listen to the episode to learn about the current standard of care and future therapies with a brief discussion about small cell transformation. Guest: Triparna Sen, MD Associate Professor Director, Lung Cancer PDX Program, Icahn School of Medicine at Mount Sinai Guest: Jacob Sands, MD Assistant Professor of Medicine, Harvard Medical School Lowe Cancer Center for Thoracic Oncology Dana Farber Cancer Institute

  --------  

  29:22
• Live from TTLC 2025: Mesothelioma and NUT Carcinoma

  In this episode of Lung Cancer Considered, host Dr. Narjust Florez leads a discussion of two of the most challenging thoracic malignancies – NUT carcinoma and mesothelioma. Listen to the episode to learn about the role of next-generation sequencing in diagnosis and treatment selection, as well as current and future targeted therapy in the management of both. Guests Melina Marmarelis, MD MSCE Assistant Professor Medical Director, UPenn Mesothelioma University of Pennsylvania Jia Luo, MD Medical Oncologist, Thoracic Oncology Program, Dana-Farber Cancer Institute Faculty, Brigham and Women's Hospital and Harvard Medical School

  --------  

  44:47
• LCC in Arabic: Chemo Immunotherapy in Metastatic NSCLC

  Descriptions: As part of the IASLC's ongoing series of podcasts in world languages, Dr. Nagla Abdel Karim moderates a discussion in Arabic with Dr. Bashir Abu Aqeel and Dr. Fawzi Abu Rous. The group discusses chemoimmunotherapy in metastatic non-small cell lung cancer.

  --------  

  15:09

Altri podcast di Scienze

Podcast di tendenza in Scienze

Su Lung Cancer Considered